Vimarsana
Biggest News Aggregation in the World

Sinovac Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sinovac Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sinovac Life Sciences Today - Breaking & Trending Today

Revisiting BRICS and Emerging New Order -By Kestér Kenn Klomegâh – Opinion Nigeria - Vimarsana News

Revisiting BRICS and Emerging New Order -By Kestér Kenn Klomegâh – Opinion Nigeria

Under Russia's presidency, BRICS will also continue focusing on strengthening cooperation along anti-terrorism, anti-corruption and anti-drug lines, as well as in the field of international information security, and continue coordinating the approaches of the BRICS countries to resolving key foreign policy issues, including at such international platforms as the UN, G20, and WTO.

The Lancet Infectious Diseases: Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers, preliminary study finds - Vimarsana News

The Lancet Infectious Diseases: Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers, preliminary study finds

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years

Nasal spray provides nearly 80 per cent protection against Covid-19, study finds - Vimarsana News

Nasal spray provides nearly 80 per cent protection against Covid-19, study finds

But the antibody spray – developed by Sinovac – has side effects, and experts say more details are needed.

Source: scmp.com
Live-attenuated COVID-19 vaccine atopic risks/adverse effect - Vimarsana News

Live-attenuated COVID-19 vaccine atopic risks/adverse effect

The goal of our study was to evaluate atopic risks and adverse effects of live-attenuated Oxford/AstraZeneca COVID-19 vaccination.

China's CanSinoBIO H1 revenue drops on weaker COVID shot demand - Vimarsana News

China's CanSinoBIO H1 revenue drops on weaker COVID shot demand

BEIJING (Reuters) - China's CanSino Biologics reported a 69.5% drop in revenue for the first six months versus a year ago, joining global and domestic...